GSK Launches OTC Fluticasone In Japan Following Switch
Executive Summary
GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.
You may also be interested in...
Japan’s New Rx-To-OTC Procedure Exacerbating Switch Blockage Says JSMI
Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.
Industry Backs Rx-To-OTC Switch Framework For SE Asia
A European trade group which counts Sanofi, Bayer and GSK among its members is calling for a prescription-to-OTC switch framework to be put in place in south-east Asia to encourage drug reclassifications across the region.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.